Resistance to the mTOR Inhibitor Temsirolimus Alters Adhesion and Migration Behavior of Renal Cell Carcinoma Cells through an Integrin α5– and Integrin β3–Dependent Mechanism

Inhibitors of the mammalian target of rapamycin (mTOR) have improved the treatment of renal cell carcinoma (RCC). However, chronic drug exposure may trigger resistance, limiting the utility of these agents. The metastatic behavior of RCC cells, susceptible (RCCpar) or resistant (RCCres) to the mTOR...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Eva Juengel, Jasmina Makarević, Michael Reiter, Jens Mani, Igor Tsaur, Georg Bartsch, Axel Haferkamp, Roman A. Blaheta
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2014-04-01
Schriftenreihe:	Neoplasia: An International Journal for Oncology Research
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S147655861400030X
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!